The three-day event highlights innovation in glaucoma therapies to ensure patients have access to the latest and most effective diagnostic tools and treatment options.
2-Jan-2020 4:55 PM EST Add to Favorites
Glaucoma Research Foundation to Honor Leaders in Glaucoma Innovation at 2020 Annual Gala in San Francisco
Ophthalmology industry innovators Vicente Anido, Jr., PhD and Thomas A. Mitro of Aerie Pharmaceuticals, Inc. will be honored at the Glaucoma 360 Annual Gala on February 6, 2020 in San Francisco.
11-Dec-2019 7:05 AM EST Add to Favorites
Preliminary applications for one-year Shaffer Grants in the amount of $50,000 are being accepted until July 15, 2019 through the Glaucoma Research Foundation website.
18-Jun-2019 2:05 PM EDT Add to Favorites
Nancy and Pat Forster chaired Glaucoma Research Foundation’s 2019 Annual Glaucoma 360 Gala, raising a record $660,000 to advance glaucoma research and education programs.
17-Jun-2019 7:05 PM EDT Add to Favorites
The Catalyst for a Cure Vision Restoration Initiative builds on 16 years of seminal scientific research, with an aim to cure glaucoma and restore vision.
14-May-2019 2:05 PM EDT Add to Favorites
The announcement during World Glaucoma Week emphasizes the need to find a cure for this disease that affects more than 60 million people worldwide.
14-Mar-2019 5:05 PM EDT Add to Favorites
For her research project seeking a new treatment to restore vision in glaucoma patients, Adriana Di Polo, PhD, professor of neuroscience at the University of Montreal, was awarded the 2019 Shaffer Prize for Innovative Glaucoma Research. The 2019...
14-Feb-2019 6:05 PM EST Add to Favorites
Glaucoma is a group of eye diseases that gradually steal sight without warning. Although the most common forms primarily affect the middle-aged and the elderly, glaucoma can affect people of all ages.
9-Jan-2019 4:05 PM EST Add to Favorites
see all news
At present, the only FDA approved method of treating glaucoma is to lower eye pressure; this slows the progression of glaucomatous optic nerve damage but does not completely halt it, and certainly does not regenerate damaged nerve tissue.
16-Jun-2017 11:45 AM EDT
Stem cells may have the potential to protect the optic nerve from further damage and slow the progression of vision loss due to glaucoma. Stem cells may also have the potential to replace ocular tissues that have degenerated in eyes with glaucoma.
17-Mar-2016 9:05 AM EDT